Carlo Scaglioni

no photo

Biography

Carlo Scaglioni focuses his practice on mergers and acquisition, joint ventures, and commercial contracts. Carlo represents Italian and foreign companies in the pharmaceutical, automotive, Private Equity and Energy sectors in both domestic and cross-border transactions as well as in drafting and negotiating commercial contracts.

Concentrations

•M&A
•Private equity
•Cross border transactions
•Joint ventures
•Pharmaceutical, medical devices and health care
•Energy
•Commercial and distribution agreements

Recognition & Leadership

Awards & Accolades

•Listed, Legal 500 EMEA
•'Corporate and M&A-Italy,' 2019, 2022 - 2025
•'Energy-Italy,' 2024

Areas of Practice (5)

  • Corporate
  • Mergers & Acquisitions
  • Private Equity
  • Life Sciences & Medical Technology
  • Energy & Natural Resources

Education & Credentials

Law School Attended:
New York University, LL.M., Corporations; University of Milan, J.D.
Year of First Admission:
2002
Admission:
2002, Italy; 2006, New York
Memberships:

Professional & Community Involvement

•Member, Milan Bar Association, 2002-Present
•Member, New York Bar Association, 2008-Present
•Member International Bar Association (IBA)
•Member of International Distribution Institute (IDI)

Military:
Corporal, Reggimento Artiglieria a Cavallo, 1999-2000
Languages:
Italian, Native and English, Fluent and German, Conversational
Birth Information:
Milan, Italy, 1974
Reported Cases:
Experience: Representative Matters: Assisted a leading Italian energy company in the negotiation of a joint venture with another Italian energy player focused on energy, water, and environmental services, aiming the main business scope to build a state-of-art environmental platform for the waste pre-treatment solution located near Ravenna (Ponticelle Area).; Assisted an Italian Private Equity fund in the sale of an Italian health care group to another private equity fund. The transaction has also included the reinvestment by some former shareholders in the acquiring entity and the carve out of the business unit related to the distribution of certain products to be used in neurosurgery to a newco.; Assisted, together with the Tokyo and Amsterdam offices, a Japanese company active in health care solutions and life science, in its acquisition of a leading European group that develops, manufactures, and supplies high tech automation and consumables to the health care industry, mainly dedicated for the histo-pathology sector.; Assisted an international real estate operator in the acquisition of 100% of the entire capital share of a company which was the owner of a transshipment plant of more than 29,000 square meters, with 80 loading bays, on approximately 144,000 square meters, located in Milan.; Assisted a wholly owned subsidiary of a pharmaceutical Chinese company, in its investment of a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral valve disease.; Assisted a leading pharmaceutical Italian company in the negotiation of an Orderly Transfer Framework Agreement that regulates, among others, the exit of a leading pharmaceutical Japanese company, the measures for the financial sustainability of the JVCo after Japanese company's exit, all the ancillary agreements necessary to the orderly transfer without disruption of the manufacturing and commercial activities managed by the JVCo to the fully owned subsidiary of the client based in Japan.; Assisted a company controlled by a leading Italian energy company in a joint-venture with another Italian Energy player concerning the realization of a plant consisting of a waste pre-treatment plant, a waste-to-energy plant, and a liquid waste treatment plant, located in Sannazzaro (Pavia), aiming the scope to manage both waste from industrial activities produced by the parties and waste produced by third-party operators.; Assisted in relation to the investment, by an affiliate of a leading Italian energy company, in the corporate capital of a company active in the context of the realization of a project consisting in the construction and running of a plant for: (i) biogas capture; (ii) upgrading of biogas to biomethane; and (iii) refining of landfill gas, at one landfill located in the South of Italy.; Assisted a primary U.S.-based private equity fund in the acquisition of an Italian bank.; Assisted a U.S. corporation in the creation of a joint venture for plating and machining of engine components in Italy.; The above representations were handled by Mr. Scaglioni prior to his joining Greenberg Traurig Santa Maria, an affiliate of Greenberg Traurig, P.A. and Greenberg Traurig, LLP.
ISLN:
915194634

Peer Reviews

This lawyer does not have peer reviews.

Client Reviews Write a Review

Location

Contact Carlo Scaglioni

Required Fields

Required Fields


By clicking on the "Submit" button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Martindale and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The Internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.